183 related articles for article (PubMed ID: 34815334)
21. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension.
Martinez C; Tsugu T; Sugimoto T; Lancellotti P
Curr Cardiol Rep; 2019 Nov; 21(12):151. PubMed ID: 31768665
[TBL] [Abstract][Full Text] [Related]
23. [Management of valvular heart disease : ESC/EACTS guidelines 2017].
Haude M
Herz; 2017 Dec; 42(8):715-720. PubMed ID: 29188357
[TBL] [Abstract][Full Text] [Related]
24. Valvular heart disease and postoperative considerations.
Miller S; Flynn BC
Semin Cardiothorac Vasc Anesth; 2015 Jun; 19(2):130-42. PubMed ID: 25975596
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics, outcomes and regional variations of acquired valvular heart disease patients undergoing cardiac surgery in China.
Lin H; Hou J; Gong J; Wu Y; Zheng Z
BMC Cardiovasc Disord; 2022 Apr; 22(1):188. PubMed ID: 35448947
[TBL] [Abstract][Full Text] [Related]
26. [When is surgery needed for minimally symptomatic or asymptomatic acquired valvulopathy?].
Acar J; Michel PL; de Gevigney G
Presse Med; 2000 Nov; 29(34):1867-75. PubMed ID: 11709821
[TBL] [Abstract][Full Text] [Related]
27. Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience.
Burzotta F; Graziani F; Trani C; Aurigemma C; Bruno P; Lombardo A; Liuzzo G; Nesta M; Lanza GA; Romagnoli E; Locorotondo G; Leone AM; Pavone N; Spalletta C; Pelargonio G; Sanna T; Aspromonte N; Cavaliere F; Crea F; Massetti M
J Am Heart Assoc; 2022 Jun; 11(11):e024404. PubMed ID: 35621200
[TBL] [Abstract][Full Text] [Related]
28. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; de Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B
Thromb Haemost; 2017 Dec; 117(12):2215-2236. PubMed ID: 29212110
[TBL] [Abstract][Full Text] [Related]
29. Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.
Coffey S; Cox B; Williams MJ
Am Heart J; 2014 Apr; 167(4):562-567.e2. PubMed ID: 24655706
[TBL] [Abstract][Full Text] [Related]
30. The advantages, pitfalls and limitations of guideline-directed medical therapy in patients with valvular heart disease.
Gill H; Chehab O; Allen C; Patterson T; Redwood S; Rajani R; Prendergast B
Eur J Heart Fail; 2021 Aug; 23(8):1325-1333. PubMed ID: 33421239
[TBL] [Abstract][Full Text] [Related]
31. Valvular procedures during ventricular assist device implantation.
Ozturk P; Engin C; Ayik F; Yagdi T; Nalbantgil S; Baysal B; Ozbaran M
Transplant Proc; 2012; 44(6):1732-4. PubMed ID: 22841257
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter aortic valve implantation: new hope in the management of valvular heart disease.
Metaxa S; Ioannou A; Missouris CG
Postgrad Med J; 2017 May; 93(1099):280-288. PubMed ID: 28104807
[TBL] [Abstract][Full Text] [Related]
33. Paravalvular Leak Assessment: Challenges in Assessing Severity and Interventional Approaches.
Fanous EJ; Mukku RB; Dave P; Aksoy O; Yang EH; Benharash P; Press MC; Rabbani AB; Aboulhosn JA; Rafique AM
Curr Cardiol Rep; 2020 Oct; 22(12):166. PubMed ID: 33037927
[TBL] [Abstract][Full Text] [Related]
34. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.
Chioncel O; Adamo M; Nikolaou M; Parissis J; Mebazaa A; Yilmaz MB; Hassager C; Moura B; Bauersachs J; Harjola VP; Antohi EL; Ben-Gal T; Collins SP; Iliescu VA; Abdelhamid M; Čelutkienė J; Adamopoulos S; Lund LH; Cicoira M; Masip J; Skouri H; Gustafsson F; Rakisheva A; Ahrens I; Mortara A; Janowska EA; Almaghraby A; Damman K; Miro O; Huber K; Ristic A; Hill L; Mullens W; Chieffo A; Bartunek J; Paolisso P; Bayes-Genis A; Anker SD; Price S; Filippatos G; Ruschitzka F; Seferovic P; Vidal-Perez R; Vahanian A; Metra M; McDonagh TA; Barbato E; Coats AJS; Rosano GMC
Eur J Heart Fail; 2023 Jul; 25(7):1025-1048. PubMed ID: 37312239
[TBL] [Abstract][Full Text] [Related]
35. Prognosis of patients with carcinoid heart disease after valvular surgery.
Manoly I; McAnelly SL; Sriskandarajah S; McLaughlin KE
Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):302-5. PubMed ID: 24812331
[TBL] [Abstract][Full Text] [Related]
36. [Monitoring of haemodynamics and function of the aortic prosthesis during transcatheter aortic valve replacement].
Margolina AA; Gruzdev KA; Imaev TE; Lepilin MG; Akchurin RS
Anesteziol Reanimatol; 2015; 60(1):63-6. PubMed ID: 26027229
[TBL] [Abstract][Full Text] [Related]
37. Current status of cardiovascular surgery in Japan, 2015 and 2016, a report based on the Japan Cardiovascular Surgery Database. 3-Valvular heart surgery.
Abe T; Nakano K; Hirahara N; Motomura N; Miyata H; Takamoto S
Gen Thorac Cardiovasc Surg; 2019 Sep; 67(9):742-749. PubMed ID: 31270746
[TBL] [Abstract][Full Text] [Related]
38. ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.
Rosenhek R; Iung B; Tornos P; Antunes MJ; Prendergast BD; Otto CM; Kappetein AP; Stepinska J; Kaden JJ; Naber CK; Acartürk E; Gohlke-Bärwolf C
Eur Heart J; 2012 Apr; 33(7):822-8, 828a, 828b. PubMed ID: 21406443
[TBL] [Abstract][Full Text] [Related]
39. The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions).
Grube E; Sinning JM; Vahanian A
Eur Heart J; 2014 Feb; 35(8):490-5. PubMed ID: 24385378
[TBL] [Abstract][Full Text] [Related]
40. Lifetime Risks of Valvular Heart Disease and Pacemaker Use in Patients With Ankylosing Spondylitis.
Ward MM
J Am Heart Assoc; 2018 Oct; 7(20):e010016. PubMed ID: 30371264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
